期刊文献+

B-flow超声显像技术在肝脏肿瘤诊断中价值的初步研究 预览

Preliminary study on diagnosis value of B-flow ultrasound imaging for liver tumor
在线阅读 下载PDF
收藏 分享 导出
摘要 目的探讨B-flow超声显像技术对肝脏肿瘤鉴别诊断的价值。方法对43例共61个肝脏肿瘤分别进行彩色多普勒血流显像、B-flow超声显像以及脉冲多普勒血流分析,其中原发性肝脏恶性肿瘤18例,转移性肝肿瘤11例,肝血管瘤14例。肝脏恶性肿瘤病例经手术病理证实,肝血管瘤病例经手术病理或临床确诊。结果 B-flow技术对肝脏肿瘤内血流检出率(90%,55/61)明显高于彩色多普勒血流显像(54%,33/61),肝脏恶性肿瘤的平均RI明显高于肝血管瘤(P<0.001)。如果以B-flow联合多普勒超声测及血流,且RI≥0.6作为诊断肝脏恶性肿瘤的指标,则敏感性为79.5%,特异性为86.7%。结论 B-flow技术在肝脏肿瘤的鉴别诊断中有一定的临床实用价值。 Objective to investigate differential diagnosis value of B-flow ultrasound imaging for liver tumor.Methods carry on color Doppler flow imaging, B-flow ultrasound imaging and pulse Doppler blood-flow analysis for 43 cases 61 liver tumors, and there were 18 cases primary liver malignant tumor, 11 cases metastatic liver tumor, 14 cases hepatic hemangioma. Liver malignant tumor cases were confirmed by operation pathology, and hepatic hemangioma cases were confirmed by operation pathology or clinical diagnosis. Results detection rate of B-flow technique for liver tumor blood flow (90%, 55/61) was significantly higher than color Doppler flow imaging (54%, 33/61), and average RI of hepatocellular carcinoma was significantly higher than hepatic hemangioma (P<0.001). If detect blood flow with B-flow combined with Doppler ultrasound, and RI≥0.6 were diagnosis index for malignant liver tumor, sensitivity was 79.5%, specificity was 86.7%.Conclusion B-flow technology has some certain clinical value in differential diagnosis of liver tumors.
作者 汤莹 刘薇 茹翱 Tang Ying;Liu Wei;Ru Ao;Department of Ultrasonography,Chengdu University Affiliated Hospital;Department of Ultrasonography,Huzhou city the First People’s Hospital
出处 《世界最新医学信息文摘(电子版)》 2016年第24期1-2,共2页 World Latest Medicine Information
基金 成都大学校青年基金项目(2080515033)
关键词 肝肿瘤 超声波检查 B-FLOW CDFI RI Hepatic tumor Ultrasonic test B-flow CDFI RI
  • 相关文献

参考文献2

二级参考文献60

  • 1吴孟超.应重视小肝癌的诊断与治疗[J].中华医学杂志,2007,87(30):2089-2091. 被引量:11
  • 2丛文铭,董 辉,冼志红. 肝脏和肝内胆管系统肿瘤[M]//吴秉铨,刘彦仿. 免疫组织化学病理诊断. 2版. 北京:北京科学技术出版社, 2013:334-45. 被引量:2
  • 3KOH C, ZHAO X, SAMALA N, et al. AASLD clinical practice guidelines: a critical review of scientific evidence and evolving recommendations[J]. Hepatology, 2013, 58(6): 2142-2152. 被引量:1
  • 4WILLIAM H, RALPH H, TIMOTHY H, et al. Surgical patholo- gy dissection : an illustrated guide[ M ]. New York : Springer, 2003 : 7 -9. 被引量:1
  • 5中华医学会临床技术操作规范·病理学分册[M].北京:人民军医出版社,2004:27-41. 被引量:1
  • 6BASS BP, ENGEL KB, GREYTAK SR, et al. A review of pre- analytical factors affecting molecular, protein, and morpho- logical analysis of formalin -fixed, paraffin - embedded ( FF- PE) tissue., how well do you know your FFPE specimen? [J]. Arch Pathol Lab Med, 2014, 138(11 ) : 1520 -1530. 被引量:1
  • 7LU XY, XI T, LAU WY, et al. Hepatocellular carcinoma ex- pressing cholangiocyte phenotype is a novel subtype with highly aggressive behavior[J]. Ann Surg Oncol, 2011, 18 (8) : 2210 -2217. 被引量:1
  • 8CAI SW, YANG SZ, GAO J, et al. Prognostic significance of mast cell count following curative resection for pancreatic ductal adenocarcinoma[J]. Surgery, 2011, 149(4): 576 -584. 被引量:1
  • 9应越英肝细胞肝癌的病理学[M]//汤钊猷.原发性肝癌上海:上海科学技术出版社,1981:115-146. 被引量:1
  • 10NAKANUMA Y, CURADO MP, FRANCESCHI S, et al. Intrahe- patic cholangiocarcinoma [ M]// BOSMAN FT, CARNEIRO F, HRUBAN RH, et al. WHO classification of tumours of the di- gestive system. 4th Ed. Lyon: IARC Press, 2010: 217 -227. 被引量:1

共引文献36

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈